Correlation Between Vanda Pharmaceuticals and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vanda Pharmaceuticals and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanda Pharmaceuticals and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanda Pharmaceuticals and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Vanda Pharmaceuticals and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanda Pharmaceuticals with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanda Pharmaceuticals and Virpax Pharmaceuticals.
Diversification Opportunities for Vanda Pharmaceuticals and Virpax Pharmaceuticals
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Vanda and Virpax is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Vanda Pharmaceuticals and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Vanda Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanda Pharmaceuticals are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Vanda Pharmaceuticals i.e., Vanda Pharmaceuticals and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vanda Pharmaceuticals and Virpax Pharmaceuticals
Given the investment horizon of 90 days Vanda Pharmaceuticals is expected to generate 0.38 times more return on investment than Virpax Pharmaceuticals. However, Vanda Pharmaceuticals is 2.62 times less risky than Virpax Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about -0.24 per unit of risk. If you would invest 469.00 in Vanda Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 50.00 from holding Vanda Pharmaceuticals or generate 10.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vanda Pharmaceuticals vs. Virpax Pharmaceuticals
Performance |
| Timeline |
| Vanda Pharmaceuticals |
| Virpax Pharmaceuticals |
Vanda Pharmaceuticals and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vanda Pharmaceuticals and Virpax Pharmaceuticals
The main advantage of trading using opposite Vanda Pharmaceuticals and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanda Pharmaceuticals position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.| Vanda Pharmaceuticals vs. Ikena Oncology | Vanda Pharmaceuticals vs. Eliem Therapeutics | Vanda Pharmaceuticals vs. HCW Biologics | Vanda Pharmaceuticals vs. RenovoRx |
| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |